Assura Plc (LON:AGR – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 35.60 ($0.44) and last traded at GBX 35.60 ($0.44), with a volume of 14356275 shares traded. The stock had previously closed at GBX 36.14 ($0.44).
Assura Stock Performance
The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.04. The firm has a 50-day simple moving average of GBX 38.42 and a 200 day simple moving average of GBX 40.35. The company has a market cap of £1.19 billion, a price-to-earnings ratio of -3,648.00, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37.
Assura Dividend Announcement
The firm also recently announced a dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, December 12th were issued a GBX 0.84 ($0.01) dividend. The ex-dividend date was Thursday, December 12th. This represents a dividend yield of 2.12%. Assura’s payout ratio is -30,000.00%.
Assura Company Profile
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Featured Stories
- Five stocks we like better than Assura
- What is the FTSE 100 index?
- 3 Cheap Small-Cap Banks for Dividend Growth Investors
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- 3 Warren Buffett Stocks to Buy Now
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.